This included SOX9 mutation (transcription factor involved in stem cell homeostasis), which was enriched in pre-cancerous lesions, whereas mutations in ARID1A (chromatin regulator), KRAS and TP53 were enriched in gastric cancers [115]. The gene discussed is KRAS; the disease is gastric cancer.